NASDAQ | DRNA

$5.27 - 0.03 (-0.566%)

3 month stock price graph

12:17 PM ET on Oct 17, 2017 Pricing delayed 20 minutes

Investors & Media

Corporate Governance

The Board of Directors of Dicerna Pharmaceuticals, Inc. (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.

Corporate Governance Documents
Title View
Code of Business Conduct and Ethics
Corporate Governance Guidelines
Audit Committee Charter
Compensation Committee Charter
Nominating and Corporate Governance Committee Charter
= add file to Briefcase